PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 228 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $133 | -38.7% | 15,956 | -2.2% | 0.01% | -30.0% |
| Q2 2023 | $217 | +14.2% | 16,314 | -0.4% | 0.01% | 0.0% |
| Q1 2023 | $190 | +111.1% | 16,386 | +48.3% | 0.01% | +100.0% |
| Q4 2022 | $90 | -99.9% | 11,047 | -0.9% | 0.01% | +25.0% |
| Q3 2022 | $65,000 | +16.1% | 11,149 | -12.1% | 0.00% | +33.3% |
| Q2 2022 | $56,000 | -67.1% | 12,685 | -32.3% | 0.00% | -62.5% |
| Q1 2022 | $170,000 | -60.4% | 18,730 | -10.6% | 0.01% | -55.6% |
| Q4 2021 | $429,000 | -17.8% | 20,945 | +2.5% | 0.02% | -28.0% |
| Q3 2021 | $522,000 | -22.3% | 20,440 | +6.3% | 0.02% | -21.9% |
| Q2 2021 | $672,000 | +74.1% | 19,223 | +66.1% | 0.03% | +52.4% |
| Q1 2021 | $386,000 | – | 11,575 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |